What is the appropriate management for a patient with type B Wolff‑Parkinson‑White (WPW) syndrome who has moderate ST‑segment depression, T‑wave abnormalities, and possible lateral ischemia?

Management of Type B WPW Syndrome with ST Depression, T-Wave Abnormalities, and Possible Lateral Ischemia

The ST-segment depression and T-wave abnormalities you are observing are most likely false-positive ischemic changes caused by the abnormal ventricular depolarization pattern inherent to WPW syndrome, not true lateral ischemia. 1

Understanding the ECG Findings in WPW

The pre-excitation pattern in WPW syndrome routinely produces ST-segment and T-wave abnormalities that mimic ischemia but are actually repolarization changes secondary to abnormal depolarization. 1, 2

• ST-segment depression typical for ischemia occurs in approximately 50% of patients with WPW syndrome during exercise testing, yet these changes are false-positives in the majority of cases. 1
• T-wave abnormalities occur in 86.6% of WPW patients when the pre-excitation pattern is present or when it disappears, with the orientation varying based on the accessory pathway location. 2
• Type B WPW (left-sided accessory pathways) characteristically produces negative delta waves in V1 and can generate ST-T changes in lateral leads that simulate ischemia. 2

Immediate Clinical Assessment

First, determine the patient's hemodynamic stability and current rhythm:

• If the patient is hemodynamically unstable with any tachyarrhythmia, perform immediate synchronized electrical cardioversion. 3
• If stable, obtain a 12-lead ECG to assess whether the patient is currently in sinus rhythm with pre-excitation, orthodromic AVRT, or pre-excited atrial fibrillation. 4

Risk Stratification for True Ischemia vs. WPW-Related Changes

To differentiate true ischemia from WPW-related repolarization abnormalities:

• Nuclear perfusion imaging or coronary CT angiography should be performed if clinical suspicion for coronary disease exists based on age, risk factors, and symptoms—not based on the ECG ST-T changes alone. 1
• The WPW pattern can mask true ischemic changes, making standard ECG interpretation unreliable for detecting coronary disease. 5, 6
• If the delta wave disappears (either spontaneously or with vagal maneuvers), observe whether the ST-T abnormalities persist—persistent changes after loss of pre-excitation suggest true ischemia, while resolution suggests WPW-related changes. 2

Definitive Management of WPW Syndrome

Catheter ablation is the definitive, first-line therapy for symptomatic WPW patients and should be strongly recommended, achieving cure rates >95% in experienced centers. 3

High-risk features mandating urgent ablation include: 3

• Accessory pathway refractory period <250 ms
• Shortest pre-excited R-R interval <250 ms during atrial fibrillation
• History of syncope
• Multiple accessory pathways
• Documented atrial fibrillation with rapid ventricular response

Critical Medication Contraindications

Never administer the following medications in WPW with wide-complex tachycardia or pre-excited atrial fibrillation, as they can precipitate ventricular fibrillation: 7, 3

• Digoxin (oral or IV)
• Diltiazem
• Verapamil
• Beta-blockers
• Intravenous amiodarone
• Adenosine (when QRS is wide/pre-excited)

These agents block the AV node, forcing conduction down the accessory pathway and increasing the risk of ventricular fibrillation. 3

Acute Arrhythmia Management (If Needed)

For hemodynamically stable pre-excited atrial fibrillation (wide QRS ≥120 ms): 3

• First-line: IV procainamide 7
• First-line: IV ibutilide 7

For orthodromic AVRT (narrow QRS <120 ms): 3

• Vagal maneuvers
• IV adenosine (safe in narrow-complex AVRT)
• Synchronized cardioversion if above fail

Common Pitfalls to Avoid

• Do not interpret ST-segment depression as definitive evidence of ischemia in WPW—it is usually a false-positive finding. 1
• Do not delay cardioversion in unstable patients while attempting pharmacologic management. 3
• Do not use AV-nodal blocking agents for rate control if there is any possibility of pre-excited atrial fibrillation. 7, 3
• Remember that successful ablation does not prevent future atrial fibrillation, especially in older patients, and ongoing monitoring may be required. 7

Recommended Approach for This Patient

Given the moderate ST depression and T-wave abnormalities in the context of Type B WPW:

1. Assess clinical probability of true coronary disease based on age, symptoms, and risk factors—not the ECG alone. 1
2. If clinical suspicion for ischemia is moderate-to-high, proceed with nuclear perfusion imaging or coronary CT angiography to definitively rule out coronary disease. 1
3. Refer for electrophysiology study and catheter ablation, which is the definitive treatment for symptomatic WPW and will eliminate the confounding ECG abnormalities. 3
4. If the patient has documented arrhythmias, syncope, or high-risk features, expedite ablation referral. 3